Portfolio (Quarterly)
Guide ↗
Fairmount Funds Management LLC
· CIK 0001802528| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | DAMORA THERAPEUTICS INC | — | 8,713,000.0 | $225.7M | 16.30% | NEW | — | $25.90 | — |
| 2 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 2,537,191.0 | $212.9M | 15.38% | +400K | +18.7% | $83.92 | +5.5% |
| 3 | COGT | COGENT BIOSCIENCES INC | Healthcare | 5,503,418.0 | $211.8M | 15.30% | -3.5M | -38.9% | $38.49 | -16.1% |
| 4 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 4,018,101.0 | $202.7M | 14.64% | — | — | $50.44 | +69.9% |
| 5 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 3,705,262.0 | $181.7M | 13.13% | — | — | $49.05 | +72.2% |
| 6 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 3,914,458.0 | $76.6M | 5.53% | — | — | $19.56 | +4.7% |
| 7 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 1,855,644.0 | $72.7M | 5.25% | -1.9M | -50.0% | $39.20 | +14.2% |
| 8 | JBIO | JADE BIOSCIENCES INC | Healthcare | 4,553,494.0 | $64.0M | 4.62% | — | — | $14.05 | +2.6% |
| 9 | — | CRESCENT BIOPHARMA INC. | — | 2,747,866.0 | $50.5M | 3.65% | — | — | $18.37 | — |
| 10 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 2,359,025.0 | $46.1M | 3.33% | +150K | +6.8% | $19.55 | +37.9% |
| 11 | — | APOGEE THERAPEUTICS INC | — | 298,647.0 | $25.1M | 1.82% | -1.8M | -85.4% | $84.17 | — |
| 12 | — | INHIBIKASE THERAPEUTICS INC | — | 8,625,000.0 | $14.5M | 1.05% | — | — | $1.68 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%